Diabetes & Metabolism Journal

Papers
(The H4-Index of Diabetes & Metabolism Journal is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Insulin Resistance: From Mechanisms to Therapeutic Strategies306
Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status178
2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association160
Diabetes Fact Sheet in Korea 2021138
Hyperinsulinemia in Obesity, Inflammation, and Cancer117
Treatment of Diabetic Kidney Disease: Current and Future116
Obesity, Diabetes, and Increased Cancer Progression110
Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications96
Assessment of Insulin Secretion and Insulin Resistance in Human85
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs81
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes72
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease69
Associations between Weight-Adjusted Waist Index and Abdominal Fat and Muscle Mass: Multi-Ethnic Study of Atherosclerosis67
Computed Tomography-Derived Myosteatosis and Metabolic Disorders51
Current Trends of Big Data Research Using the Korean National Health Information Database49
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence48
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control45
Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea40
Links between Thyroid Disorders and Glucose Homeostasis38
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-1935
Incidence and Prevalence of Type 1 Diabetes Mellitus among Korean Children and Adolescents between 2007 and 2017: An Epidemiologic Study Based on a National Database35
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins35
Study on Risk Factors of Peripheral Neuropathy in Type 2 Diabetes Mellitus and Establishment of Prediction Model34
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association31
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Yea30
Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus29
Present and Future of Digital Health in Diabetes and Metabolic Disease27
0.030366897583008